Tetradecyltrimethylammonium bromide
Tetradecyltrimethylammonium bromide Basic information
- Product Name:
- Tetradecyltrimethylammonium bromide
- Synonyms:
-
- alkyl*trimethylammoniumbromide*(c14,5%c16)
- alkyltrimethylammoniumbromide
- alkyltrimethylammoniumbromide(c14,5%c16)
- Tetradecanaminium,N,N,N-trimethyl-,bromide
- tetradecyltrimethyl-ammoniubromide
- MYRTRIMONIUM BROMIDE
- (1-Tetradecyl)trimethylammonium bromide
- TETRADECYLTRIMETHYLAMMONIUM BROMIDE, FOR IPC
- CAS:
- 1119-97-7
- MF:
- C17H38N.Br
- MW:
- 336.39
- EINECS:
- 214-291-9
- Product Categories:
-
- Pharmaceutical raw materials
- Ammonium Bromides (Quaternary)
- Quaternary Ammonium Compounds
- 1119-97-7
- Mol File:
- 1119-97-7.mol
Tetradecyltrimethylammonium bromide Chemical Properties
- Melting point:
- 245-250 °C(lit.)
- Density
- 1.1328 (rough estimate)
- vapor pressure
- 0Pa at 25℃
- refractive index
- 1.5260 (estimate)
- storage temp.
- Store below +30°C.
- solubility
- H2O: 10 % (w/v)
- form
- Fine Crystalline Powder
- color
- White
- PH
- pH (50g/l, 25℃ : 4.0~6.0
- Water Solubility
- 20 g/100 mL
- Sensitive
- Hygroscopic
- λmax
- λ: 240 nm Amax: ≤0.08
λ: 250 nm Amax: ≤0.05
λ: 260 nm Amax: ≤0.04
λ: 500 nm Amax: ≤0.02 - Merck
- 14,6336
- BRN
- 3633227
- Stability:
- Stable. Hygroscopic. Incompatible with strong oxidizing agents.
- InChIKey
- CXRFDZFCGOPDTD-UHFFFAOYSA-M
- LogP
- 2.2 at 20℃
- CAS DataBase Reference
- 1119-97-7(CAS DataBase Reference)
- EPA Substance Registry System
- Tetradecyl trimethyl ammonium bromide (1119-97-7)
Safety Information
- Hazard Codes
- C
- Risk Statements
- 34
- Safety Statements
- 26-36/37/39-45-27
- RIDADR
- UN 3263 8/PG 2
- WGK Germany
- 3
- RTECS
- BS5776000
- F
- 3
- TSCA
- Yes
- HazardClass
- 8
- PackingGroup
- II
- HS Code
- 29239000
- Toxicity
- LD50 in mice, rats (mg/kg): 12.0, 15.0 i.v. (Issomaa, Bjondahl)
MSDS
- Language:English Provider:SigmaAldrich
- Language:English Provider:ACROS
- Language:English Provider:ALFA
Tetradecyltrimethylammonium bromide Usage And Synthesis
Physical properties
Cetrimide is a white fine powder crystal with a melting point of 245°C to 250°C. A rough estimate of its density is 1.1328. It is soluble in water with a solubility of 20 g/100 mL.
Description
MiTMAB (1119-97-7) is a dynamin I/II inhibitor targeting the dynamin-phospholipid interaction and inhibiting dynamin GTPase activity with a Ki=940nM.1 Rapidly and reversibly inhibits multiple forms of endocytosis with no acute cellular damage1. A useful pharmacological tool for studying dynamin-mediated trafficking events.2 Induces cytokinesis failure and apoptosis in human cancer cells.3 Induces cytoprotective autophagy in human Jurkat T cells.4
Uses
Myristyltrimethylammonium has been used in a study to assess a surfactant-controlled synthetic method to obtain a nanophase of mesoporous ceria-zirconia solid solution containing cationic defects in the crystalline structure.??It has also been used in a study to determine the low molecular weight of organic acids in soils and plants by capillary zone electrophoresis.
Uses
Disinfectant; deodorant; laboratory reagent.
Definition
Myristyltrimethylammonium bro-mide.
General Description
Myristyltrimethylammonium bromide is a cationic/zwitterionic type of surfactant.
Purification Methods
Crystallise the bromide from acetone or a mixture of Me2CO and >5% MeOH or Me2CO/EtOH. Wash it with diethyl ether and dry it in a vacuum oven at 60o. It is a cationic detergent. Its solubility is 1g/5g H2O. [Dearden & Wooley J Phys Chem 91 2404 1987, Shelton et al. J Am Chem Soc 68 754 1946, Beilstein 4 III 419, 4 IV 813.]
References
1) Quan et al. (2007), Myristal trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecules dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II; Mol. Pharmacol., 72 1425 2) Joshi et al. (2011), Development and validation of a stability indicating method for the enantioselective estimation of omeprazole enantiomers in the enteric-coated formulations by high performance liquid chromatography; Mol. Cancer, 104 78 3) De Beco et al. (2009), Endocytosis is required for E-cadherin redistribution at mature adherens junctions; Proc. Natl. Acad. Sci. USA, 106 7010 4) Kim et al. (2016), Inhibition of autophagy enhances dynamin inhibitor-induced apoptosis via promoting Bak activation and mitochondrial damage in human Jurkat T cells; Biochem. Biophys. Res. Commun., 478 1609
Tetradecyltrimethylammonium bromideSupplier
- Tel
- 13850073005
- 13939264@qq.com
- Tel
- 18230666727 17575750356
- 2837798034@qq.com
- Tel
- 021-58957966 18930537195
- wouchina@126.com
- Tel
- 15253208962
- sddjrhhgyl@126.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
Tetradecyltrimethylammonium bromide(1119-97-7)Related Product Information
- Hexadecyl trimethyl ammonium bromide
- Octadecy trimethyl ammonium bromide
- Cetrimide
- Tetradecyl trimethyl ammonium chloride
- N-Hexadecyltrimethylammonium chloride
- Dodecyltrimethylammonium Bromide
- 1-TETRADECANESULFONIC ACID SODIUM SALT
- SODIUM TETRADECYL SULFATE
- Dodecyltrimethylammonium chloride
- Trimethylstearylammonium Chloride
- dodecylbis(2-hydroxyethyl)methylammonium chloride
- Vecuronium bromide
- TETRAOCTADECYLAMMONIUM BROMIDE
- Dimethylditetradecylammonium bromide
- Rocuronium bromide
- CETYLDIMETHYLETHYLAMMONIUM BROMIDE
- TETRAHEXADECYLAMMONIUM BROMIDE
- Ammonium bromide